Multi-omics analysis of esophageal cancer for elucidating carcinogenic mechanisms and identifying diagnostic markers

Multi-omics analysis of esophageal cancer for elucidating carcinogenic mechanisms and identifying diagnostic markers - Multi-omics analysis of esophageal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008072

Enrollment

100

Registered

2012-05-31

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who will undergo radical surgery Patient who gives his/her informed consent to participating in this research Patient whose tumor is large enough for pathological diagnosis after collecting sample

Exclusion criteria

Exclusion criteria: Patient whose HBs-Ag test, HCV-Ab test , or TPHA test is positive Patient who has received steroids systemically Patient who suffers from systemic infectious disease Patient who suffers from active multiple primary cancers Patient who has no ability to judge

Design outcomes

Primary

Measure	Time frame
Relationship between results of omics-based analysis and cliniophathological factors	—

Countries

Japan

Contacts

Public ContactSoji Ozawa

Tokai University School of Medicine Department of Gastroenterological Surgery

tokai.eso@tokai-u.jp0463-93-1121

Outcome results